Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells.

Autor: Kim JH; Korea Stem Cell Bank, Center for Biomedical Sciences, Korea National Institute of Health (KNIH), Osong, South Korea., Kurtz A; Charité Universitätsmedizin Berlin, Berlin, Germany., Yuan BZ; Cell Collection and Research Center, National Institutes for Food and Drug Control, Beijing, China., Zeng F; Shanghai Institute of Medical Genetics, Shanghai Jiao Tong University, Shanghai, China., Lomax G; California Institute for Regenerative Medicine, Oakland, CA, USA., Loring JF; Department of Molecular Medicine Center for Regenerative Medicine The Scripps Research Institute, San Diego, CA, USA., Crook J; ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer Research Institute, AIIM Facility, University of Wollongong, Fairy Meadow, New South Wales, Australia.; Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.; Department of Surgery, St. Vincent's Hospital, The University of Melbourne, Fitzroy, Victoria, Australia., Ju JH; Catholic University, Seoul, Korea., Clarke L; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Inamdar MS; Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India., Pera M; Jackson Laboratories, Bar Harbor, ME, USA., Firpo MT; Stem Cell Institute and Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Sheldon M; Department of Genetics, Rutgers, The State University of New Jersey, Piscataway, NJ., Rahman N; University of Toronto, Toronto, Ontario, Canada., O'Shea O; UK Stem Cell Bank, Division of Advanced Therapies, NIBSC, South Mimms, UK., Pranke P; Stem Cell Research Institute, Federal University of Rio Grande do Sul, Porto Alegre, Brazil., Zhou Q; Institute of Zoology, Chinese Academy of Sciences, Beijing, China., Isasi R; Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL, USA., Rungsiwiwut R; Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Kawamata S; Foundation for Biomedical Research and Innovation, Kobe, Japan., Oh S; Stem Cell Group, Bioprocessing Technology Institute, A*STAR, Singapore., Ludwig T; WiCell Research Institute, Madison, WI, USA., Masui T; Keio University/SKIP, Yokahama, Japan., Novak TJ; Cellular Dynamics International, Madison, WI, USA., Takahashi T; University of Kyoto, Kyoto, Japan., Fujibuchi W; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan., Koo SK; Korea Stem Cell Bank, Center for Biomedical Sciences, Korea National Institute of Health (KNIH), Osong, South Korea., Stacey GN; UK Stem Cell Bank, Division of Advanced Therapies, NIBSC, South Mimms, UK.
Jazyk: angličtina
Zdroj: Stem cells translational medicine [Stem Cells Transl Med] 2017 Nov; Vol. 6 (11), pp. 1956-1962. Date of Electronic Publication: 2017 Oct 24.
DOI: 10.1002/sctm.17-0144
Abstrakt: This article summarizes the recent activity of the International Stem Cell Banking Initiative (ISCBI) held at the California Institute for Regenerative Medicine (CIRM) in California (June 26, 2016) and the Korean National Institutes for Health in Korea (October 19-20, 2016). Through the workshops, ISCBI is endeavoring to support a new paradigm for human medicine using pluripotent stem cells (hPSC) for cell therapies. Priority considerations for ISCBI include ensuring the safety and efficacy of a final cell therapy product and quality assured source materials, such as stem cells and primary donor cells. To these ends, ISCBI aims to promote global harmonization on quality and safety control of stem cells for research and the development of starting materials for cell therapies, with regular workshops involving hPSC banking centers, biologists, and regulatory bodies. Here, we provide a brief overview of two such recent activities, with summaries of key issues raised. Stem Cells Translational Medicine 2017;6:1956-1962.
(© 2017 The Authors Stem Cells Translational Medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.)
Databáze: MEDLINE
Externí odkaz: